<DOC>
	<DOCNO>NCT02572882</DOCNO>
	<brief_summary>The Microbiome trial non-randomized , open-label , crossover , multi-center study p-inulin patient hemodialysis-dependent end-stage renal disease .</brief_summary>
	<brief_title>Gut Microbiome p-Inulin Hemodialysis</brief_title>
	<detailed_description>This primary objective exploratory study characterize safety tolerability p-inulin alter composition function human gut microbiome , thereby reduce generation gut-derived uremic toxin , improve gut barrier function attenuate systemic inflammation patient treat maintenance hemodialysis . The study also aim assess feasibility conduct full-scale trial p-inulin . The primary efficacy parameter trial intra- inter-participant variability gut metabolites bacterial composition . Secondary parameter interest include tolerability safety p-inulin , willingness hemodialysis patient enroll study require repeat collection stool sample , participant adherence agent treatment specimen collection schedule .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Dysbiosis</mesh_term>
	<criteria>Maintenance hemodialysis therapy endstage renal disease At least 18 year age At least 90 day since hemodialysis initiation Selfreported average stool frequency least 1 every day For woman childbearing potential , willingness use highly effective method birth control 4 week last dose pinulin . Ability provide consent Use prebiotics probiotic past 8 week Consumption probiotic yogurt past 2 week Use antibiotic within past 8 week Presence HIV infection , chronic wound infection , osteomyelitis , current hemodialysis Inflammatory bowel disease , chronic diarrhea , current C. difficile infection Cirrhosis chronic active hepatitis Anticipated kidney transplantation , change peritoneal dialysis , transfer another dialysis unit within 9 month Expected survival less 9 month Pregnancy , anticipated pregnancy , breastfeed Incarceration Participation another intervention study Severe anemia define hemoglobin &lt; 9.0 g/dl within past 4 week document dialysis unit patient record</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>hemodialysis</keyword>
	<keyword>p-inulin</keyword>
	<keyword>gut microbiome</keyword>
</DOC>